However, whether FA can against maternal HFD-induced placental inflammation and oxidative stress and alleviate IUGR by upregulating SIRT1, thus inhibiting NF-κB and activating the Nrf2 pathway, has not been reported. The gene discussed is SIRT1; the disease is fetal growth restriction.